These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8467290)

  • 1. Graft failure following neutrophil-specific alloantigen mismatched allogeneic BMT.
    Klumpp TR; Herman JH; Mangan KF; Macdonald JS
    Bone Marrow Transplant; 1993 Mar; 11(3):243-5. PubMed ID: 8467290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT.
    Inukai T; Goi K; Tezuka T; Uno K; Nemoto A; Takahashi K; Sato H; Akahane K; Hirose K; Honna H; Kuroda I; Kagami K; Nakamoto K; Taniguchi K; Nakazawa S; Sugita K
    Bone Marrow Transplant; 2009 Feb; 43(3):229-35. PubMed ID: 18806835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristics.
    Lamb LS; Gee AP; Parrish RS; Lee C; Walker M; Geier S; Harris G; Pati A; Godder K; Henslee-Downey PJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1021-7. PubMed ID: 8807109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
    Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation.
    Grandage VL; Cornish JM; Pamphilon DH; Potter MN; Steward CG; Oakhill A; Marks DI
    Bone Marrow Transplant; 1998 Apr; 21(7):687-90. PubMed ID: 9578308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.
    Nagler A; Brautbar C; Slavin S; Bishara A
    Bone Marrow Transplant; 1996 Nov; 18(5):891-7. PubMed ID: 8932842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.
    Lamb LS; Szafer F; Henslee-Downey PJ; Walker M; King S; Godder K; Pati AR; Best R; Steinman L; Geier SS
    Exp Hematol; 1995 Dec; 23(14):1595-600. PubMed ID: 8542952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation.
    Stroncek DF; Shapiro RS; Filipovich AH; Plachta LB; Clay ME
    Transfusion; 1993 Feb; 33(2):158-63. PubMed ID: 8430456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT.
    Klumpp TR; Herman JH; Schnell MK; Goldberg SL; Mangan KF
    Bone Marrow Transplant; 1996 Sep; 18(3):559-64. PubMed ID: 8879617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia.
    Chiang KY; Van Rhee F; Godder K; Bridges K; Adams S; Mehta J; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Mar; 27(5):507-10. PubMed ID: 11313684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
    Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
    Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.